The developer of a $1 billion mixed-use community in north Scottsdale wants to add hundreds of luxury condos to a project decades in the making. Now, DMB Associates Inc. is awaiting a recommendation ...

CLEVELAND — Cuyahoga County Prosecutor Michael O'Malley sent a cease-and-desist letter Thursday ordering county officials to immediately stop work on a new jail facility. He is alleging the nearly $1 ...

A first-of-its-kind deal killed two offshore wind projects and reinvested the funds in fossil fuels. The next day, the nation’s largest offshore wind farm started delivering power. Reading time 3 ...

The series "House of David" is a three-season trilogy about the biblical figure's life. Season 2 of "House of David" is now available for streaming. The show streams on Wonder Project available ...

Disney‘s much heralded $1 billion investment in OpenAI is over as the Sam Altman-led tech giant said Tuesday that it will be shuttering its stand-alone Sora text-to-video app. “The deal is not moving ...

Later this year, an MTA mobile wash facility may be relocated to 213 Meadow Street, clearing the way for Monitor Point, a nearly $1 billion development that promises affordable waterfront housing and ...

A new report from the Garden State Initiative argues that legislative earmarks added to New Jersey budget are growing rapidly, increasing costs for residents while reducing transparency in the state’s ...

GameSpot may get a commission from retail offers. "At this stage, we are satisfied with the direction in which the project is developing," Bloober CEO Piotr Babieno said (per Inwestycje.pl, via ...

Getting your Trinity Audio player ready... Sam Ehlinger turned down chances to leave Denver in 2025. Now he’s back for 2026, too. The quarterback and the Broncos agreed to terms on a one-year, $2 ...

Dirt is turning on one of the largest mixed-use developments in Central Texas. The District, a massive $1 billion project slated to transform living in a growing city north of Austin, has moved into ...

EXTRA-PC: A phase II trial of masofaniten (EPI-7386) and enzalutamide with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC). This is an ASCO ...